Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Assaf
    Junior Member
    • Jan 2012
    • 3

    Tophat complains

    Hi all,

    It is my first post here, and it is nice to e-meet you.

    I have 454 transcriptome sequencing results, which I want to map to their reference genome, in order to identify splice junctions, reads depth, and to produce contigs. I decided to do that in a pipeline with the Bowtie, Tophat, and cufflinks programs.

    I first created bowtie index files based on the genome reference (*.ebwt), and also converted my sff transcriptome files into fastq files (using biopython). And now i'm trying to run Tophat with the basename of bowtie index files, and the fastq.

    After about 10min Tophat is terminated with the following complain:
    ....
    [Mon Jan 2 16:33:02 2012] Joining segment hits
    [FAILED]
    Error executing: /home/assaf/programs1/tophat-1.3.3.Linux_x86_64/bam_merge ./tophat_out/tmp/left_kept_reads.candidates_and_unspl.bam ./tophat_out/tmp/left_kept_reads.unspl.bam ./tophat_out/tmp/left_kept_reads.candidates.bam

    In the file sam_merge.log
    this is what I got:

    Warning: no input BAM records found.
    GList error (GList.hh:932):Invalid list index: 0

    I can indeed see that the file left_kept_reads.candidates_and_unspl.bam was not created, so bam_merge is in troubles, but why ?

    Maybe you can give me a hint ?

    Thanks in advanced,
    Assaf
  • Ambily
    Junior Member
    • Feb 2012
    • 6

    #2
    Hi Assaf,

    I am getting the same error too with the latest version of TopHat. Did you manage to fix it?

    Looking forward to you response.
    Ambily

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 12:17 PM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 11:41 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...